17 min listen
The weight loss drug everyone’s talking about
FromThe Decibel
ratings:
Length:
20 minutes
Released:
Jan 4, 2023
Format:
Podcast episode
Description
Ozempic and other semaglutide drugs have been hailed as a very effective treatment for obesity, but shortages, affordability and doctors’ willingness to prescribe it are still keeping people who might benefit from it off the drug.Health reporter Carly Weeks explains how the drug works and how it may force our society to rethink how we perceive obesity.Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com
Released:
Jan 4, 2023
Format:
Podcast episode
Titles in the series (100)
Why last year’s hottest stocks are cooling off: The pandemic promised a gold mine for companies like Zoom, Shopify, and Peloton. And at first, these companies did see a boost in their stock value. But the ground started to shift at the end of 2021 and now these stocks, which are often darlings of retail investors, are seeing substantial drops. Report on Business reporter and columnist Tim Kiladze explains what has led to this investor whiplash and how a lot of trading on the stock market has become detached from the actual value of some companies. by The Decibel